Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by LIBING LU
Inflammation Promotes Oral Squamous Carcinoma Immune Evasion via Induced Programmed Death Ligand‑1 Surface Expression
Oncology Letters
Cancer Research
Oncology
Related publications
The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis
Journal of Advances in Medicine and Medical Research
Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Deubiquitination and Stabilization of Programmed Cell Death Ligand 1 by Ubiquitin-Specific Peptidase 9, X-Linked in Oral Squamous Cell Carcinoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Journal of Cancer
Oncology
Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients
Cancer Management and Research
Oncology
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
Expression Patterns of Programmed Death Ligand 1 Correlate With Different Microenvironments and Patient Prognosis in Hepatocellular Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Cancers
Cancer Research
Oncology
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
